[Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?].

Der Nervenarzt
G PaslakisE Sobanski

Abstract

Attention-deficit/hyperactivity disorder (ADHD) in adults is often associated with a comorbid substance use disorder (SUD). To date, no treatment algorithms are available. The question of whether the administration of methylphenidate (MPH) is justified in the treatment of adult patients with ADHD and comorbid SUD still remains unclear. While animal studies indicate an addictive potential of intravenous application of the drug, controlled oral treatment with MPH does not seem to carry the potential for abuse in humans. It remains controversial whether MPH treatment of ADHD during childhood protects against the development of SUD during adulthood. Although data remain inconsistent, a small number of studies and our own clinical observations of ADHD patients with SUD treated with MPH support a reduction not only of ADHD-related symptoms, but also of craving and substance abuse. The treatment of the adult ADHD with comorbid SUD with MPH should be conducted after a risk-benefit assessment, taking into consideration the abused substances, the motivation to abstinence and the quality of the physician-patient relationship; it should be evaluated critically, monitored closely and accompanied by treatment of the SUD and specific psychoth...Continue Reading

References

Jan 1, 1991·Archives of General Psychiatry·S MannuzzaK A Addalli
Aug 26, 1998·Behavioural Brain Research·T SagvoldenD Berger
Nov 14, 1998·Journal of Learning Disabilities·N M Lambert, C S Hartsough
Jun 1, 2000·The Journal of Clinical Psychiatry·H SchubinerE P Schoener
Jul 6, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·E P Noble
Jul 13, 2000·Drug and Alcohol Dependence·M M Vanyukov, R E Tarter
Aug 10, 2000·The American Journal on Addictions·M A Schuckit
Apr 28, 2001·Pharmacology, Biochemistry, and Behavior·S H KollinsC R Rush
Jul 21, 2001·Annals of the New York Academy of Sciences·D J MarksJ M Halperin
Jul 21, 2001·Annals of the New York Academy of Sciences·M A Sullivan, F Rudnik-Levin
Oct 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C L BrandonF J White
Dec 4, 2001·Nature Neuroscience·Susan L AndersenWilliam A Carlezon
Feb 28, 2002·Behavioural Brain Research·Mary V Solanto
May 1, 2002·Current Opinion in Pediatrics·Wendy Klein-Schwartz
Jan 28, 2003·Biological Psychiatry·David MichelsonDenái Milton
Feb 20, 2003·The Journal of Clinical Psychiatry·Katie A BuschDouglas G Jacobs
Nov 5, 2003·The American Journal of Psychiatry·Nora D Volkow, James M Swanson
Dec 17, 2003·Biological Psychiatry·William A CarlezonSusan L Andersen
Jan 8, 2004·Journal of Clinical Psychopharmacology·Stephen V FaraoneJoseph Biederman
Feb 26, 2004·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Russell A BarkleyKenneth Fletcher
Aug 24, 2004·European Child & Adolescent Psychiatry·Philip Asherson, UNKNOWN IMAGE Consortium
Dec 1, 2004·Psychiatrische Praxis·Monika JohannNorbert Wodarz
Jan 12, 2005·Nature Neuroscience·Jan ReuterChristian Büchel
Jan 22, 2005·Current Opinion in Pharmacology·Friedbert Weiss
Jun 14, 2005·Biological Psychiatry·Stephen V FaraonePamela Sklar
Sep 22, 2005·Journal of Psychopharmacology·Timothy E Wilens, Joseph Biederman
Oct 26, 2005·Human Molecular Genetics·Anita ThaparMichael J Owen
Nov 3, 2005·Journal of Child and Adolescent Psychopharmacology·Jeffrey J Wilson, Frances R Levin

❮ Previous
Next ❯

Citations

Mar 25, 2011·Attention Deficit and Hyperactivity Disorders·Regina TaurinesMarcel Romanos
Nov 19, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Michael Soyka, Jochen Mutschler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.